Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Disposition to Issuer of 30,000 ISCO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | International Stem Cell CORP (ISCO) | Disposition to Issuer | 30,000 | n/a |
| Sep 15, 2026 | International Stem Cell CORP (ISCO) | Sale | 32,802 | $10.5K |
| Aug 31, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 50,000 | $189.0K |
| Aug 4, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 10,000 | n/a |
| Jun 24, 2026 | International Stem Cell CORP (ISCO) | Grant/Award | 30,000 | n/a |
| Jan 14, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 12,196 | n/a |
| Jun 20, 2025 | International Stem Cell CORP (ISCO.OB) | Grant/Award | 30,000 | n/a |
| Jan 6, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 25,000 | n/a |
| Jun 13, 2024 | International Stem Cell CORP (ISCO.OB) | Grant/Award | 30,000 | n/a |
| Mar 7, 2024 | Ambrx Biopharma, Inc. (AMAM) | Disposition to Issuer | 12,142 | n/a |